Eton Pharmaceuticals Inc — Quarterly Financial Statistics (NASDAQ:ETON) | MetaTrader

Open full chart

Financials

Overview Relatórios Statistics Dividends

Quarterly Annual

Cash from operating activities 516 K-765 K2.09 M7.96 M12.03 M 21.31 M Cash from investing activities 038.13 M00284 K 38.42 M Cash from financing activities 385 K31.61 M394 K00 32.01 M Free cash flow 516 K-8.9 M2.09 M7.96 M11.74 M 12.89 M

Notícias

FDA-Zulassung für DESMODA: Eton Pharmaceuticals zielt auf Markt für Diabetes insipidus

DESMODA oral solution receives FDA approval for diabetes insipidus

Lizenz-Deal für Medikament beflügelt Eton Pharmaceuticals-Aktie

Eton Pharmaceuticals stock rises after licensing ultra-rare disease drug

Eton Pharmaceuticals lizenziert Wirkstoffkandidaten für extrem seltene Krankheit

Eton Pharmaceuticals licenses ultra-rare disease treatment candidate

Implied Volatility Surging for Eton Pharmaceuticals Stock Options

Eton Pharmaceuticals, Inc. (ETON) Reports Q3 Loss, Beats Revenue Estimates

Eton Pharmaceuticals: EPS verfehlt Schätzungen um 0,07 $ - Umsatz besser als erwartet

Eton Pharmaceuticals earnings missed by $0.07, revenue topped estimates

Airbnb, Monster Beverage, Take-Two and more set to report earnings Thursday

Eton Stock Has Focused Growth But Valuation Limits Upside: Why I Choose To Hold